Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL
Fotocitizen / Pixabay

Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL
Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome
source: pixabay.com

Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome

In a recent press release, biopharmaceutical company Rhythm Pharmaceuticals (“Rhythm”) announced positive data from a Phase 3 clinical trial. During the trial, Rhythm evaluated setmelanotide for patients with Bardet-Biedl syndrome…

Continue Reading Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome
Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients
mcmurryjulie / Pixabay

Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients

According to a publication from EurekAlert, a clinical trial of setmelanotide, an experimental anti-obesity drug, is set to begin soon at the Alberta Diabetes Institute (of the University of Alberta).…

Continue Reading Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients

LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020

The Importance of Braille For any child with a rare disease that leads to blindness or visual impairment such as Stargardt disease, Usher Syndrome, Alström syndrome, or Retinal Blindness life…

Continue Reading LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020